Givaudan | GIVN - Operating Profit


Givaudan reported CHF610M in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Air Liquide EUR 2.84B 6.65B Dec/2025
Akzo Nobel EUR 254M 37M Mar/2026
Anheuser-Busch USD 4.07B 24M Mar/2026
Arkema EUR 80.9M 55.9M Mar/2026
Associated British Foods GBP 620M 205M Jun/2026
BASF EUR 1.4B 1.58B Mar/2026
Bayer EUR 3.53B 2.42B Mar/2026
Beiersdorf EUR 504M 312M Dec/2025
British American Tobacco GBP 5B 86M Dec/2025
Covestro EUR -324M 5.72B Dec/2025
Croda International GBP 113M 53.55M Dec/2024
Danone EUR 1.86B 48M Dec/2025
Diageo GBP 3.26B 1.92B Dec/2025
Fresenius EUR 713M 139M Dec/2025
Fresenius Medical Care EUR 268M 395M Mar/2026
Givaudan CHF 610M 149M Dec/2025
Heineken EUR 1.97B 40M Dec/2025
Henkel EUR 1.42B 187M Dec/2025
International Flavors Fragrances USD 272M 159M Mar/2026
Johnson Matthey GBP 198M 56M Jun/2026
Kerry EUR 463.5M 94.2M Dec/2024
Lonza CHF 673M 243M Jun/2025
L'Oréal EUR 3.92B 824.8M Dec/2025
Merck EUR 1.05B 572M Mar/2026
Nestle CHF 6.84B 293M Dec/2025
Pernod Ricard EUR 1.61B 644M Dec/2025
Reckitt Benckiser GBP 747M 92M Dec/2024
SGS CHF 253M 45.5M Dec/2024
Sika AG CHF 724.9M 73.2M Dec/2025
Solvay EUR 118M 58M Mar/2026
Tate & Lyle GBP 110M 19M Jun/2026
Umicore EUR 713.86M 409.56M Dec/2025
Victrex GBP 19M 3.9M Jun/2026